ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy (2025)

When: May 17–22, 2024
Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101
Marriott Marquis San Diego Marina | 333 West Harbor Dr. San Diego, CA 92101

Research: 26 ResMed-supported abstracts will be presented at ATS. Full list below. Highlights:

Innovation Hub: Healthcare of Today, Looking Towards Tomorrow: Digital Innovations and Patient Centricity

Booth #1442: Featuring ResMed’s latest innovations in respiratory care:

Treatment of sleep-disordered breathing with adaptive servo-ventilation (READ-ASV) in opioid users – a European registry

Sunday, May 19, 2024
9:15 AM -11:15 AM

8-year Trends in Obesity, Type 2 Diabetes, and Glucagon-like Peptide-1 (GLP-1) Use in Patients With Obstructive Sleep Apnea

Sunday May 19, 2024
9:15 AM - 11:15 AM

Impact of CPAP Termination on Permanent Work Disability in Obstructive Sleep Apnea: A French Nationwide Alaska Database Analysis

Sunday May 19, 2024
9:15 AM - 4:15 PM

Tailoring Social Support to Improve PAP Therapy Usage in Obstructive Sleep Apnea

Sunday May 19, 2024
9:15 AM - 4:15 PM

Examining Alignment of Patient Medication-taking Behaviors With Inhaler Usage Recommendations in Chronic Obstructive Pulmonary Disease and Asthma

Sunday May 19, 2024
9:15 AM - 4:15 PM

Using Natural Language Processing for Qualitative Research: Insights From a Real-world Analysis

Sunday May 19, 2024
9:15 AM - 4:15 PM

A Qualitative Analysis of Perceptions and Awareness of Air Pollution and Its Health Effects in Asthma Among Asthma-care Professionals Across Southern California

Monday May 20, 2024
9:15 AM - 4:15 PM

An Estimate of the Prevalence of Obstructive Sleep Apnea in the United States Into 2050

Monday May 20, 2024
9:15 AM - 4:15 PM

All-cause Mortality in Obstructive Sleep Apnea: Systematic Literature Review Including Randomised Trials and Confounding Adjusted Non-randomised Controlled Studies and Meta-analysis of Positive Airway Pressure Treatment

Monday May 20, 2024
2:15 PM - 4:15 PM

Impact of Positive Airway Pressure (PAP) Therapy on Hospitalization in Obstructive Sleep Apnea (OSA): Analysis of a German Healthcare Database

Monday May 20, 2024
2:15 PM - 4:15 PM

Hypoxic Burden but Not AHI Predicts Risk of Cardiovascular Events: A Secondary Analysis of the RICCADSA Clinical Trial

Monday May 20, 2024
2:15 PM - 4:15 PM

A Digital Quality Improvement Program Delivered By Clinical Pharmacists Can Reduce Acute Care Visits In COPD

Monday May 20, 2024
2:15 PM - 4:15 PM

Hands-on Simulation Training With Home Ventilators Improves PCCM Fellow Understanding of Nocturnal NIV in Chronic Hypercapnia

Monday May 20, 2024
2:15 PM - 4:15 PM

The Economic and Health Burden of COPD in North America Through 2050: A Scenario Analysis Based on Two Large Data Sources

Tuesday May 21, 2024
9:15 AM - 11:15 AM

Impact of long-term domiciliary noninvasive ventilation (NIV) on severe exacerbations and survival in Patients with Chronic Obstructive Pulmonary Disease (COPD): a nationwide cohort study using multistate models

Tuesday May 21, 2024
9:15 AM - 11:15 AM

Nocturnal Hypoxemic Burden and Micro- and Macrovascular Disease in Patients With Type 2 Diabetes

Tuesday May 21, 2024
9:15 AM - 11:15 AM

Risk Factors for Severe Exacerbation Occurrence Among Patients With COPD-OSA Overlap Syndrome Using Bilevel Positive Airway Pressure Therapy

Tuesday May 21, 2024
9:15 AM - 4:15 PM

Adherence to Glucagon-like Peptide-1 Receptor Agonists (GLP-1s) in Obstructive Sleep Apnea Patients With and Without Type 2 Diabetes

Tuesday May 21, 2024
2:15 PM - 4:15 PM

Treatment of sleep-disordered breathing with adaptive servo-ventilation (READ-ASV) – outcomes in patients with treatment-emergent or persistent central sleep apnea (TE-CSA) in a European registry

Tuesday, May 21, 2024
2:15 PM – 4:15 PM

A Scenario-based Modeling Study to Project the Future Burden of COPD in the United States Accounting for the Effects of E-cigarettes

Tuesday May 21, 2024
2:15 PM - 4:15 PM

The Impact Of Weight Change On Positive Airway Pressure Use In Patients With Obstructive Sleep Apnea And Obesity

Tuesday May 21, 2024
2:15 PM - 4:15 PM

Real World GLP-1 Adherence in Patients with Treated Obstructive Sleep Apnea

Tuesday May 21, 2024
2:15 PM - 4:15 PM

Less REM Sleep Predicts Mortality in Adults With Coronary Artery Disease and Obstructive Sleep Apnea: The RICCADSA Trial

Tuesday May 21, 2024
2:15 PM - 4:15 PM

Gender Specific Differences in a National Sample of Individuals with Comorbid Insomnia, Obstructive Sleep Apnea (OSA), and Depression

Wednesday May 22, 2024
8:15 AM - 10:15 AM

Use of Weight Management Regimens Among Positive Airway Pressure-Treated Patients With Obstructive Sleep Apnea and Obesity

Wednesday May 22, 2024
11:00 AM - 1:00 PM

A Mixed-methods Exploration of Patient Perspectives on Pap Therapy Initiation: Implications for Improved Outreach and Education

Wednesday May 22, 2024
11:00 AM - 1:00 PM

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy (2025)

FAQs

How much does the inspire implant cost? ›

The Inspire sleep apnea implant costs about $30,000–$40,000 for the device and surgery, keeping in mind, doctors may charge different amounts for surgical procedures. This price does not include any potential insurance coverage.

What is a PAP treatment for sleep apnea? ›

With PAP therapy, you wear a mask during sleep. A portable machine gently blows pressurized room air from into your upper airway through a tube connected to the mask. This positive airflow helps keep the airway open, preventing the collapse that occurs during apnea, thus allowing normal breathing.

What is the new pill for sleep apnea? ›

Apnimed is a company that's developed a new oral drug for sleep apnea – currently called AD109. AD109 combines the drugs aroxybutynin and atomoxetine. Aroxybutynin is used to treat symptoms of an overactive bladder, while atomoxetine is used to treat attention deficit hyperactivity disorder.

What is the downside of inspire sleep apnea device? ›

Once the therapy is turned on, some patients may experience discomfort from stimulation, tongue abrasion, mouth dryness, and discomfort from the presence of the device. The majority of these events are resolved either on their own, with medication, or by adjusting the therapy settings.

Will insurance pay for inspire? ›

If you meet the FDA indications for Inspire therapy and your BMI is between 32-40*, it's likely your insurance will pay for Inspire therapy. This may or may not require a prior authorization process that your clinic and/or the Inspire team can conveniently manage for you.

Is inspire implant worth it? ›

90% of recipients have stopped snoring. 79% have fewer sleep apnea events. 94% are satisfied with the results – less daytime fatigue and fewer associated medical issues. 96% say Inspire is better than CPAP.

Can you fix sleep apnea without a CPAP? ›

CPAP therapy is an effective treatment option, but it may not be right for everyone. APAP, BiPAP, and EPAP therapies are other devices to consider. Alternative therapies, like surgery or oral appliances, and lifestyle changes like weight loss, exercise, and physical or positional therapy can also ease OSA symptoms.

What is the most successful treatment for sleep apnea? ›

Continuous Positive Airway Pressure (CPAP)

A tube connects the machine to a mask that covers the sleeper's mouth, nose, or both. Then, the CPAP machine blows air into the sleeper's airway, which helps keep it open during sleep. CPAP is considered the most effective OSA treatment, but it must be used nightly.

Can a CPAP reverse sleep apnea? ›

Unfortunately, we can't really call sleep apnea treatments like positive airway pressure (PAP) or continuous positive airway pressure (CPAP) sleep apnea cures. They usually work very well in eliminating sleep apnea symptoms, but they're a means of treating and living with the condition, not of getting rid of it.

What is the 2024 treatment for sleep apnea? ›

INDIANAPOLIS , April 17, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10 mg or 15 mg) significantly reduced the apnea-hypopnea index (AHI) compared to placebo, achieving the primary ...

What is the limitless drug for sleep apnea? ›

Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting medication used primarily to treat narcolepsy. Modafinil is also approved for stimulating wakefulness in people with sleep apnea and shift work sleep disorder.

What is the new breakthrough for sleep apnea? ›

The study has shown that tirzepatide can dramatically reduce the apnea-hypopnea index (AHI) by up to 63%. This index measures the severity of sleep apnea by recording the number of times breathing is partially or completely blocked during sleep.

Who cannot use inspire? ›

Contraindications for the use of Inspire implant include the following: Central + mixed apneas >25% of the total apnea-hypopnea index (AHI) Any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate.

Is there a maskless CPAP machine? ›

We invented a micro-CPAP device that has no hoses, no cords, and no mask. And we did it because too many people have sleep apnea, and too many of those don't wear their CPAP masks.

Will Medicare pay for an inspire implant? ›

If you and your doctor can demonstrate that you meet all of the criteria, Inspire is considered medically necessary, so Medicare will cover it.

How long does the Inspire implant last? ›

The battery in Inspire is designed to last for approximately 11 years. Once it is running low, it is replaced during a simple outpatient procedure. How long is the recovery time after surgery? Recovery time after surgery will vary.

How painful is the Inspire surgery? ›

The procedure to implant Inspire is typically an outpatient procedure lasting about 3 hours. For some special circumstances, your physician may recommend a single night stay in the hospital. Pain after the procedure varies but for most patients is not severe.

Why can't obese people use inspire? ›

Additionally, people who are extremely overweight tend to have excess fatty tissue in the neck are that pushes in on the upper airway even with the Inspire stimulation. If you are not sure of your BMI, use the calculator at the end of this page.

How much do you have to weigh for inspire? ›

Inspire therapy has been clinically tested for people with a body mass index (BMI) up to 40. Over 90% 1 of U.S. adults are within this range. Most insurance policies have a BMI policy in place for Inspire therapy coverage. Talk to your provider or Inspire therapy-trained doctor for more information.

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Otha Schamberger

Last Updated:

Views: 5822

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Otha Schamberger

Birthday: 1999-08-15

Address: Suite 490 606 Hammes Ferry, Carterhaven, IL 62290

Phone: +8557035444877

Job: Forward IT Agent

Hobby: Fishing, Flying, Jewelry making, Digital arts, Sand art, Parkour, tabletop games

Introduction: My name is Otha Schamberger, I am a vast, good, healthy, cheerful, energetic, gorgeous, magnificent person who loves writing and wants to share my knowledge and understanding with you.